Veeva on technology migration and genAI adoption in life sciences
Last month, Veeva announced multiple generative artificial intelligence (genAI) capabilities in its Vault CRM such as Vault CRM Bot and…
All articles by Phalguni Deswal
Phalguni Deswal
@Phalguni_GD
Phalguni Deswal is reporter in the healthcare and pharmaceutical sector. With a background in medicine, Phalguni has experience working in the Indian healthcare sector. Phalguni is interested in metabolic drug therapies, digital health technologies, and drug development.
-
-
Delcath to trial Hepzato drug device combo in colorectal cancer
Delcath System has received clearance from the US Food and Drug Administration (FDA) for an investigational new drug (IND) application…
-
FDA labels Baxter’s haemodialysis machine recall Class I
Baxter has issued a correction for its AK 98 haemodialysis machines, with the US Food and Drug Administration (FDA) classifying…
-
Silo Pharma partners with Kymanox to develop ketamine implant
US-based Silo Pharma has partnered with North Carolina-based Kymanox to jointly design and develop a subcutaneous insertion device for SP-26,…
-
SyntheticMR looks to expand AI and cloud capabilities with Combinostics acquisition
Swedish magnetic resonance imaging (MRI) software developer SyntheticMR is looking to expand its offerings to include cloud-based and AI-driven platforms…
-
Boston Scientific expands infusion offerings with Intera Oncology acquisition
Boston Scientific has signed a definitive agreement to acquire a Boston-based infusion pump maker Intera Oncology. Intera’s main asset is…
-
Medtronic acquires Fortimedix Surgical to boost surgical portfolio
Medtronic has acquired Netherlands-based Fortimedix Surgical in a bid to boost its surgical and endoscopy portfolio. Fortimedix Surgical made the…
-
Daiichi Sankyo exec on purposeful data collection
Daiichi Sankyo’s VP of digital excellence, Dr Patrick Markt-Niederreiter, has outlined how the pharma makes ‘very conscious’ decisions about the…
-
Intelligent gears up for FDA approval of fingerprint drug detection device
US based company Intelligent Bio Solutions has released “strong initial results” from a pharmacokinetic (PK) study and is one step…
-
Nihon Kohden expands neurology portfolio with Ad-Tech Medical acquisition
Nihon Kohden has expanded its portfolio of neurology electrode devices by acquiring a 71.4% stake in NeuroAdvanced Corp., the parent…